Kenvue Inc. (NYSE:KVUE) Shares Bought by Focus Financial Network Inc.

Focus Financial Network Inc. grew its position in Kenvue Inc. (NYSE:KVUE) by 10.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 11,529 shares of the company’s stock after purchasing an additional 1,095 shares during the quarter. Focus Financial Network Inc.’s holdings in Kenvue were worth $246,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the business. Summit Trail Advisors LLC increased its position in Kenvue by 60.4% during the 4th quarter. Summit Trail Advisors LLC now owns 17,651 shares of the company’s stock valued at $377,000 after buying an additional 6,646 shares in the last quarter. Principle Wealth Partners LLC grew its stake in shares of Kenvue by 3.7% during the fourth quarter. Principle Wealth Partners LLC now owns 14,194 shares of the company’s stock worth $303,000 after acquiring an additional 500 shares during the last quarter. Savant Capital LLC increased its holdings in shares of Kenvue by 5.2% during the fourth quarter. Savant Capital LLC now owns 16,241 shares of the company’s stock valued at $347,000 after acquiring an additional 798 shares in the last quarter. Angeles Wealth Management LLC purchased a new position in shares of Kenvue in the 4th quarter valued at approximately $216,000. Finally, Richard C. Young & CO. LTD. boosted its stake in Kenvue by 5.1% in the 4th quarter. Richard C. Young & CO. LTD. now owns 391,313 shares of the company’s stock worth $8,355,000 after purchasing an additional 18,925 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Kenvue Trading Up 2.3 %

Shares of Kenvue stock opened at $21.94 on Friday. The firm has a 50-day simple moving average of $21.33 and a two-hundred day simple moving average of $22.02. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.69 and a current ratio of 1.00. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $24.46. The company has a market cap of $42.07 billion, a P/E ratio of 41.40, a price-to-earnings-growth ratio of 2.16 and a beta of 1.45.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Thursday, February 6th. The company reported $0.26 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.26. Kenvue had a return on equity of 20.97% and a net margin of 6.66%. As a group, equities analysts predict that Kenvue Inc. will post 1.05 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be paid a $0.205 dividend. The ex-dividend date of this dividend is Wednesday, February 12th. This represents a $0.82 dividend on an annualized basis and a yield of 3.74%. Kenvue’s dividend payout ratio is currently 154.72%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Citigroup decreased their price target on shares of Kenvue from $25.00 to $21.00 and set a “neutral” rating for the company in a report on Wednesday, January 15th. Canaccord Genuity Group lowered their price target on Kenvue from $27.00 to $24.00 and set a “buy” rating for the company in a research report on Friday, February 7th. Deutsche Bank Aktiengesellschaft lowered Kenvue from a “buy” rating to a “hold” rating and cut their price objective for the company from $25.00 to $24.00 in a report on Thursday, December 12th. Bank of America lifted their target price on Kenvue from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Tuesday, October 22nd. Finally, Barclays cut their price target on shares of Kenvue from $23.00 to $21.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, Kenvue has a consensus rating of “Hold” and a consensus target price of $23.00.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.